Skip to main content
Explore URMC


John J. Treanor, M.D.

Infectious Diseases

Clinical Interests

General Infectious Diseases

Contact Information

Phone Numbers

Fax: (585) 442-9328

Office: (585) 275-5871

URMFGA member of the University of Rochester Medical Faculty Group

groupAn Accountable Health Partner

assignmentAccepting New Patients


Professional Background

Dr. Treanor is a graduate of the University of Rochester Medical School and a residency in Internal Medicine at the University of Vermont. He returned to the University of Rochester for Fellowship in Infectious Diseases and also trained at the Laboratory of Infectious Diseases, NIH. Dr. Treanor primarily sees inpatients with general ID problems at UR Medicine and has a small outpatient clinic.


My research interests are primarily focused on control of influenza with vaccines and antivirals, and on the safety and immunogenicity of vaccines for emerging infectious diseases. Our group currently conducts clinical studies evaluating candidate live attenuated influenza vaccines for prevention of pandemic influenza, and studies to document and evaluate the priming effects of pandemic vaccines on subsequent booster vaccines. As director of the New York Influenza Center of Excellence, I collaborate with colleagues in microbiology and immunology to perform detailed evaluations of the human humoral and cellular immune responses to influenza infection and vaccination. Our group is also active in clinical trials to evaluate new vaccines for Norovirus and other viral pathogens in the field and in the human experimental infection model.


Faculty Appointments


  • Infectious Disease - American Board of Internal Medicine
  • Internal Medicine - American Board of Internal Medicine


BA | Canisius College

MD | Univ Rochester Sch Med/Dent

Post-doctoral Training & Residency

06/01/1979 - 06/30/1980
Internship in Internal Medicine at Medical Center Hospital of Vermont

07/01/1982 - 06/30/1985
Fellowship in Internal Medicine: Infectious Disease at Univ. of Rochester School of Medicine and Dentistry

07/01/1980 - 07/31/1982
Residency in Internal Medicine at Medical Center Hospital of Vermont

VIEW ALL expand_more


Title: Attenuated Influenza Vaccines and Uses Thereof
U.S. Serial #: 14/695,544
Filed: Apr 24, 2015
Invented By: AndrewCox, StephenDewhurst, BaekKim, JohnTreanor

Title: Method for Increasing the Attenuation and Safety of a Live-attenuated Influenza Vaccine (LAIV)
U.S. Serial #: 14/905,320
Filed: Jul 18, 2014
Invented By: AndrewCox, StephenDewhurst, BaekKim, JohnTreanor


Journal Articles

Ramani S, Neill FH, Ferreira J, Treanor JJ, Frey SE, Topham DJ, Goodwin RR, Borkowski A, Baehner F, Mendelman PM, Estes MK, Atmar RL. "B-Cell Responses to Intramuscular Administration of a Bivalent Virus-like Particle Human Norovirus Vaccine." Clinical and vaccine immunology : CVI.. 2017 Mar 1; Epub 2017 Mar 01.

Treanor JJ, Chu L, Essink B, Muse D, El Sahly HM, Izikson R, Goldenthal KL, Patriarca P, Dunkle LM. "Stable emulsion (SE) alone is an effective adjuvant for a recombinant, baculovirus-expressed H5 influenza vaccine in healthy adults: A Phase 2 trial." Vaccine.. 2017 Feb 7; 35(6):923-928. Epub 2017 Jan 11.

Treanor JJ. "CLINICAL PRACTICE. Influenza Vaccination." The New England journal of medicine.. 2016 Sep 29; 375(13):1261-8.




Could Sugar Boost the Power of Some Antibiotics?


Flu Season 2010-11: A Crash Course


John Treanor, M.D.